课题基金 / 基金详情

The 4th World Parkinson Congress is a four-day scientific conference designed to bring the US and global Parkinson's community together for a variety of high level and novel educational symposia.

The 4th World Parkinson Congress is a four-day scientific conference designed to bring the US and global Parkinson's community together for a variety of high level and novel educational symposia.
第四届世界帕金森大会是为期四天的科学会议,旨在将美国和全球帕金森病界聚集在一起,举办各种高水平和新颖的教育研讨会。
批准号:
9194917
负责人:
SERGE E PRZEDBORSKI
金额:
$5.0万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-20 至 2017-09-19

项目摘要

项目成果

SERGE E PRZEDBORSKI的其他基金

相似基金

相关文献

中文摘要
翻译
第四届世界帕金森大会(WPC 2016)的目的是解决持续的 需要就帕金森病(PD)的多方面问题进行全球对话 并提出解决方案,包括新的研究方法和更好的护理模式 对于PD患者来说。 WPC 2016将于2016年9月20日至23日举行,是世界上唯一一个 在帕金森病领域的会议,使整个PD社区聚集在一起,为高- 水平科学和奠定会议。与会代表代表神经科学家, 医生、PD患者、护理伙伴、护士、康复专家、社会 工作人员、政府代表和倡导团体的成员, 近70个国家为期四天的课程强调了帕金森病科学的进步 以及对艾滋病患者的护理模式。美国的研究人员 世界其他地区的科学进步将有助于他们探索新的 想法和建立合作,否则他们可能不会考虑。包容和 在这一重要会议上鼓励初级调查人员也有助于建立网络 并接触到该领域的领导者,可以激励那些新的PD保持专注于 疾病,这是非常需要的! PD社区的广泛支持和参与(超过170个合作组织 来自近50个国家)表明,WPC是这些广泛传播的 小组见面并建立合作关系。它将允许并鼓励 卫生专业人员,研究人员和PD患者以及可能不会 否则见面。这种专家、倡导者和想法的交叉授粉将 推动新的创新研究,确定未满足需求的潜在解决方案, 为PD患者提供治疗,并激励代表们继续他们的工作。 48名委员会成员,包括患有PD(PwP)的人,设计了一个精心设计的 关于PD独特方面的计划,以帮助加深研究人员的承诺, 临床医生对PD的研究和促进研究较少的PD方面。的 该计划预计将使PwPs和护理人员接触研究,并增加对 参与临床试验。超过180位来自世界各地的演讲者将应邀出席。 PD社区的会议格式,以最大限度地提高学习潜力和对话, 包括大型和中型以及令人难以置信的亲密圆桌会议 只有一位专家和10位参与者在激烈地讨论一个指定的主题。 上午的三次大型全体会议将研究PD和DBS的大脑回路, 和机制的散发性PD,并给出了更新的干细胞和iPs细胞。这些 全体会议将为以后每天的会议作进一步讨论奠定基础。会 既科学又生活与帕金森病的海报,以及海报会议, 旨在最大限度地提高代表之间互动的图尔斯之旅。四个最 每天在基础和临床研究、临床治疗学和 生活质量将在一个口头的热门话题讨论会和海报图尔斯将介绍 举行,密切关注该领域最有希望的工作,并增加 社区的对话与合作。
英文摘要
The purpose of the 4th World Parkinson Congress (WPC 2016) is to address a continued need for worldwide dialogue on the multifaceted problems of Parkinsonʼs disease (PD) and to propose solutions, including new approaches to research and better models of care for people with PD. The WPC 2016, to be held from September 20 to 23, 2016, is the only international meeting in the field of Parkinsonʼs that brings the whole PD community together for high- level scientific and lay sessions. Delegates at the meeting represent neuroscientists, physicians, people with PD, care partners, nurses, rehabilitation specialists, social workers, government representatives, and members of the advocacy community from nearly 70 countries. The four-day program highlights advancements in the science of PD and models of care for people living with the disease. Exposing researchers from the US to the scientific advancements made in other parts of the world will help them explore new ideas and build collaborations they might otherwise not have considered. Inclusion and encouragement of junior investigators in this important meeting also allows for networking and exposure to leaders in the field and can inspire those new to PD to stay dedicated to the disease, which is greatly needed! Broad support and involvement from the PD community (over 170 partnering organizations from nearly 50 countries) shows that the WPC is the right venue for these widespread groups to meet and build collaborations. It will allow and encourage interactions between health professionals, researchers, and people with PD and caregivers who might not otherwise meet. Such cross-pollination of experts, as well as advocates, and ideas will spur new innovative research, identify potential solutions to unmet needs, advance therapies for people with PD and inspire delegates to continue their work. Forty-eight committee members, including people with PD (PwP), designed an elaborate program about unique aspects of PD to help deepen the commitment of researchers and clinicians to PD research and foster research on less studied aspects of PD. The program is expected to expose PwPs and caregivers to research and increase interest in participating in clinical trials. Over 180 speakers are being invited from all areas of the PD community with sessions formatted to maximize the learning potential and dialogue, including large and moderately sized as well as incredibly intimate round table sessions with just one expert and 10 participants discussing one assigned topic intensely. The three large morning plenaries will look at the brain circuits in PD and DBS, genes and mechanisms of sporadic PD, and give an update on stem cells and iPs cells. These plenaries will set the stage for further discussion in later sessions each day. There will be both Scientific and Living with Parkinsonʼs posters as well as Poster sessions and tours which are designed to maximize interaction among the delegates. The four most outstanding posters each day in basic and clinical research, clinical therapeutics and quality of life will be presented in an oral ʻHot Topicsʼ session and poster tours will be held, paying keen attention to the most promising work in the field and to increase dialogue and collaboration in the community.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Circuit-specific, chemogenetic neuromodulation in nonhuman primates.
A multiplexable in vivo perturbation toolkit to identify genes affecting neurodegeneration in a model of synucleinopathy
Defining Immune Cell Heterogeneity in Human ALS and Mouse Model of the Disease
Defining immune cell heterogeneity in human ALS and mouse model of the disease
海外基金